ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Orthofix Medical Inc

Orthofix Medical Inc (OFIX)

16.76
-0.25
(-1.47%)
Closed September 14 4:00PM
16.76
0.02
(0.12%)
After Hours: 7:47PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
16.76
Bid
16.48
Ask
17.03
Volume
233,432
16.49 Day's Range 17.32
9.575 52 Week Range 41.17
Market Cap
Previous Close
17.01
Open
17.28
Last Trade Time
Financial Volume
$ 3,952,430
VWAP
16.9318
Average Volume (3m)
300,135
Shares Outstanding
38,174,785
Dividend Yield
-
PE Ratio
-4.22
Earnings Per Share (EPS)
-3.97
Revenue
746.64M
Net Profit
-151.4M

About Orthofix Medical Inc

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing prod... Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients. Show more

Sector
Surgical,med Instr,apparatus
Industry
Medical Instruments & Machines
Headquarters
Lewisville, Texas, USA
Founded
1980
Orthofix Medical Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker OFIX. The last closing price for Orthofix Medical was $17.01. Over the last year, Orthofix Medical shares have traded in a share price range of $ 9.575 to $ 41.17.

Orthofix Medical currently has 38,174,785 shares outstanding. The market capitalization of Orthofix Medical is $649.35 million. Orthofix Medical has a price to earnings ratio (PE ratio) of -4.22.

OFIX Latest News

Shareholders of Orthofix Medical Inc. Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX

Shareholders of Orthofix Medical Inc. Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX PR Newswire NEW YORK, Sept. 12, 2024 NEW YORK, Sept. 12, 2024...

Shareholders that lost money on Orthofix Medical Inc.(OFIX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Shareholders that lost money on Orthofix Medical Inc.(OFIX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire NEW YORK, Sept. 9, 2024 NEW YORK, Sept. 9, 2024...

The Gross Law Firm Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - OFIX

The Gross Law Firm Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - OFIX PR Newswire NEW YORK, Sept. 5, 2024 NEW YORK, Sept. 5...

Patrick Fisher Joins Orthofix as President of Global Orthopedics Business

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Patrick Fisher as President of the Orthofix Global Orthopedics business. In...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.462.8220858895716.317.6715.7323611016.90129585CS
44.0531.864673485412.7117.6712.6128527615.92735318CS
122.8220.229555236713.9417.6712.0830013514.69032202CS
263.728.330781010713.0617.679.57551530813.12308258CS
52-24.21-59.092018550240.9741.179.57530549116.72177466CS
156-35.44-67.892720306552.254.99.57522763321.02856243CS
26000017.55000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
205.22k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
50.1M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.87M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.91M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.24M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
30.45M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
34.54M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
5.06M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
238.43M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
183.73M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
136.36M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
127.78M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
120.81M

OFIX Discussion

View Posts
Monksdream Monksdream 6 months ago
OFIX 10Q due March 5
👍️0
Renee Renee 6 years ago
OFIX, Jeffrey Hammel, CPA, Brian McCollum, Kenneth Mack and Bryan McMillan SEC Litigation:

https://www.sec.gov/litigation/admin/2018/34-82933.pdf

👍️0
Renee Renee 12 years ago
OFIX: SEC Litigation:

http://www.sec.gov/litigation/litreleases/2012/lr22412.htm

U.S. SECURITIES AND EXCHANGE COMMISSION

Litigation Release No. 22412 /July 11, 2012

Securities and Exchange Commission v. Orthofix International N.V., United States District Court for the Eastern District of Texas, Case No. 4:12-CV-419 (filed July 10, 2012)

SEC CHARGES ORTHOFIX INTERNATIONAL WITH FCPA VIOLATIONS


The Securities and Exchange Commission today charged Texas-based medical device company Orthofix International N.V. with violating the Foreign Corrupt Practices Act (FCPA) when a subsidiary paid routine bribes referred to as “chocolates” to Mexican officials in order to obtain lucrative sales contracts with government hospitals.

The SEC alleges that Orthofix’s Mexican subsidiary Promeca S.A. de C.V. bribed officials at Mexico’s government-owned health care and social services institution Instituto Mexicano del Seguro Social (IMSS). The “chocolates” came in the form of cash, laptop computers, televisions, and appliances that were provided directly to Mexican government officials or indirectly through front companies that the officials owned. The bribery scheme lasted for several years and yielded nearly $5 million in illegal profits for the Orthofix subsidiary.

Orthofix agreed to pay $5.2 million to settle the SEC’s charges.

According to the SEC’s complaint filed in U.S. District Court for the Eastern District of Texas, the bribes began in 2003 and continued until 2010. Initially, Promeca falsely recorded the bribes as cash advances and falsified its invoices to support the expenditures. Later, when the bribes got much larger, Promeca falsely recorded them as promotional and training costs. Because of the bribery scheme, Promeca’s training and promotional expenses were significantly over budget. Orthofix did launch an inquiry into these expenses, but did very little to investigate or diminish the excessive spending. Later, upon discovery of the bribe payments through a Promeca executive, Orthofix immediately self-reported the matter to the SEC and implemented significant remedial measures. The company terminated the Promeca executives who orchestrated the bribery scheme.

The SEC’s proposed settlement is subject to court approval. Orthofix consented to a final judgment ordering it to pay $4,983,644 in disgorgement and more than $242,000 in prejudgment interest. The final judgment would permanently enjoined the company from violating Sections 13(b)(2)(A) and 13(b)(2)(B) of the Securities Exchange Act of 1934. Orthofix also agreed to certain undertakings, including monitoring its FCPA compliance program and reporting back to the SEC for a two-year period.

Orthofix also disclosed today in an 8-K filing that it has reached an agreement with the U.S. Department of Justice to pay a $2.22 million penalty in a related action.

The SEC’s investigation was conducted by Carol Shau and Alka N. Patel in the Los Angeles Regional Office. The SEC acknowledges and appreciates the assistance of the U.S. Department of Justice’s Criminal Division-Fraud Section and the Federal Bureau of Investigation.

SEC Complaint:

http://www.sec.gov/litigation/complaints/2012/comp22412.pdf
👍️0
Penny Roger$ Penny Roger$ 13 years ago
~ Monday! $OFIX ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $OFIX ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=OFIX&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=OFIX&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=OFIX
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=OFIX#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=OFIX+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=OFIX
Finviz: http://finviz.com/quote.ashx?t=OFIX
~ BusyStock: http://busystock.com/i.php?s=OFIX&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=OFIX >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 13 years ago
Orthofix International N.V. (Orthofix) is a diversified orthopedic products company. The Company offers a range of surgical and non-surgical products for the Spine, Orthopedics, Sports Medicine and Other Products market sectors. The Company’s products are designed to address the bone-and-joint health needs of patients of all ages. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. The Company operates in three segments: Spine, Orthopedics and Sports Medicine. Its primary research and development facilities are located in Fairfield, New Jersey; Verona, Italy; Lewisville, Texas; and Vista, California. During the year ended December 31, 2010, it closed certain facilities in the United States and Mexico and it subleased its facility in Boston, Massachusetts.

http://www.google.com/finance?q=OFIX
👍️0

Your Recent History

Delayed Upgrade Clock